Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Delta Asia International Corporation (6762:TWSE), powered by AI.
Delta Asia International Corporation is currently trading at $181.50. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Delta Asia International Corporation on Alpha Lenz.
View Delta Asia International Corporation's valuation metrics on Alpha Lenz.
“Delta Asia International Corporation's ROE is 1.8%. Explore profitability and growth together.”
Ask for details →Delta Asia International Corporation is a specialist in the manufacturing of medical devices, focusing on the design, analysis, and production of both parts and final products for the healthcare sector. Headquartered in Taoyuan City, Taiwan, and established in 2004, the company serves global markets with a particular emphasis on the Americas and Asia. Its operations encompass mold development, injection molding, tooling, and automated assembly, enabling the supply of complex components for minimally invasive surgical devices, robotic surgical disposables, blood glucose monitors, insulin delivery systems, and orthopedic equipment. Delta Asia International Corporation maintains advanced production capabilities such as cleanroom environments and precision CNC machining, supporting stringent quality control for medical applications. The firm is notable for its ability to manage demanding supply chains and deliver tailored solutions to both multinational corporations and regional clients. Through continuous investment in technology and quality systems, Delta Asia plays a pivotal role in supporting innovation and reliability within the medical device industry.
“Delta Asia International Corporation's ROE is 1.8%. Explore profitability and growth together.”
Ask for details →Delta Asia International Corporation (ticker: 6762) is a company listed on TWSE in the Healthcare sector (Medical Devices). It has approximately 183 employees.
The current price is 181.5 with a P/E ratio of -x and P/B of -x.
ROE is 1.80% and operating margin is 8.51%. Annual revenue is $694M.